Sharon Tetlow's Net Worth

$48.4 Thousand

Estimate Recalculated Sep 8, 2024 07:31PM EST

Who is Sharon Tetlow?

Sharon Tetlow does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include DICE Therapeutics, Inc., CATALYST BIOSCIENCES, INC., Structure Therapeutics Inc., Ocera Therapeutics, Inc., and CELL GENESYS INC.

SEC CIK

Sharon Tetlow's CIK is 0001328565

Past Insider Trading and Trends

2021 was Sharon Tetlow's most active year for acquiring shares with 5 total transactions. Sharon Tetlow's most active month to acquire stocks was the month of May. 2009 was Sharon Tetlow's most active year for disposing of shares, totalling 9 transactions. Sharon Tetlow's most active month to dispose stocks was the month of September. 2014 saw Sharon Tetlow paying a total of $17,487.00 for 3,000 shares, this is the most they've acquired in one year. In 2008 Sharon Tetlow cashed out on 9,051 shares for a total of $28,103.35, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

DICE Therapeutics, Inc. No price found

Investor

Sharon Tetlow used to own units in Common Stock but no longer holds any shares there. From 2021 to 2023 Sharon Tetlow disposed a total of 49,841 shares of DICE Therapeutics, Inc..

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-49.84K
—
—
0
Aug 9
Form 4
—
0
—
—
0
Jun 7
Form 4
—
0
—
—
0
Sep 14
Form 3
—
0
—
—
0
No matching records found

CATALYST BIOSCIENCES, INC. (GYRE) Snapshot price: $13.77

Investor

Sharon Tetlow owns 3,635 units of Common Stock which is worth $50,053.95. In the year 2020 Sharon Tetlow filed a total of 6 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 9
Form 4
+88.15%
1.7K
—
—
3.63K
Jul 1
Form 4
—
0
—
—
0
Jun 11
Form 4
∞
1.93K
—
—
1.93K
Apr 1
Form 4
—
0
—
—
0
Jan 15
Form 3
—
0
—
—
0
No matching records found

Structure Therapeutics Inc. (GPCR) Snapshot price: $36.9

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 25
Form 3
—
0
—
—
0
No matching records found

Ocera Therapeutics, Inc. No price found

Acting CFO & Treasurer

Sharon Tetlow owns 3,000 units of Common Stock. In the year 2014 Sharon Tetlow filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
3K
$5.83
$17,487.00
3K
Jul 11
Form 3
—
0
—
—
0
No matching records found

CELL GENESYS INC No price found

SVP & CFO

Sharon Tetlow used to own units in Common Stock but no longer holds any shares there. In the year 2005 Sharon Tetlow filed a total of 9 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-18.45K
—
—
0
Oct 14
Form 4
-32.91%
-9.05K
$3.11
-$28,103.35
18.45K
Jul 31
Form 4
—
0
—
—
0
Feb 6
Form 4
+1,000.00%
25K
—
—
27.5K
Jul 30
Form 4
—
0
—
—
0
Feb 7
Form 4
—
0
—
—
0
Feb 7
Form 4
∞
2.5K
$4.91
$12,275.00
2.5K
Jun 8
Form 4
—
0
—
—
0
Jun 1
Form 3
—
0
—
—
0
No matching records found